Semax/Selank, 10mg/10mg

Semax

Semax is a synthetic peptide that has been studied in research settings for its potential effects on neurochemical signaling, cognitive processes, and stress-related physiological responses. It is structurally related to adrenocorticotropic hormone (ACTH) fragments and has been investigated for its interaction with neurotransmitter systems, neurotrophic factors, and immune-related pathways.

Neurocognitive and Neuroprotective Research

Semax has been examined in preclinical and limited clinical studies for its potential association with cognitive function, including learning and memory. Experimental models have explored its interaction with monoaminergic systems, such as serotonin and dopamine pathways, as well as its relationship with neurotrophic factors including brain-derived neurotrophic factor (BDNF). Research has also investigated its role in neuroprotective models, including conditions involving oxidative stress and ischemic injury. Findings from these studies suggest potential associations with cellular signaling, inflammatory modulation, and neuronal support under controlled conditions; however, results vary by model and require further validation.

Neurodegenerative Research

Semax has been studied in experimental models related to amyloid-beta aggregation and neuronal viability. Some in vitro and animal studies have examined its interaction with metal-ion-associated peptide aggregation and its potential influence on cholinergic neuron function. These findings are preliminary and have not been confirmed in large-scale clinical studies.

Stress and Immune Response Research

Semax has been evaluated in models of physiological and environmental stress, where it has been associated with changes in immune signaling, cytokine expression, and oxidative stress markers. Experimental findings suggest possible interactions with both cellular and humoral immune responses under controlled conditions. Additional studies have explored its relationship with stress-related physiological responses, including changes in endocrine signaling and tissue-level effects in animal models. These observations remain limited to research environments and are not fully characterized.

Vascular and Cellular Signaling Research

Semax has also been investigated in experimental models of vascular and tissue response, particularly in the context of gene expression related to endothelial function, immune activity, and cellular migration. These studies suggest potential involvement in signaling pathways relevant to cellular adaptation and repair processes, though further research is needed.

Selank 

Selank is a synthetic peptide that has been studied in research settings for its potential effects on neurochemical signaling, cognitive processes, and stress-related physiological responses. It has been investigated for its interaction with neurotransmitter systems, including pathways associated with gamma-aminobutyric acid (GABA), as well as broader neuroendocrine and immune-related mechanisms.

Neurocognitive and Behavioral Research

Selank has been examined in preclinical and limited clinical studies for its potential influence on behavioral and cognitive parameters. Research has explored its association with anxiety-related behaviors and cognitive functions such as memory and attention under controlled conditions. Some studies have investigated its relationship with neurotrophic factors, including brain-derived neurotrophic factor (BDNF), in specific brain regions. Findings vary by model and experimental design and remain under investigation.

Immune System Research

Selank has also been studied for its potential role in immune signaling. Experimental data suggest it may influence the expression of genes associated with cytokines, chemokines, and related receptors. These observations indicate possible interactions with immune regulatory pathways, though their significance has not been fully established.

Stress and Physiological Response Research

In animal models, Selank has been evaluated for its association with physiological responses to stress. Studies have explored changes in stress-related biomarkers and tissue-level responses under experimental conditions. These findings suggest potential involvement in stress-adaptation pathways; however, results are limited to controlled research environments.

Semax/Selank is not approved by the U.S. Food and Drug Administration for human use. Its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. This compound is intended strictly for laboratory research purposes and is not for human or veterinary use.